Hemoglobinuria - 76 Studies Found Completed : Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab : Hemoglobinuria, Paroxysmal : 2005-07-19 : Drug: eculizumab Completed : Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients : Hemoglobinuria, Paroxysmal : 2010-10-18 Completed : Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes : Hemoglobinuria : 2010-08-30 Completed : Study of Global Coagulation Tests in Patients With Paroxysmal Nocturnal Haemoglobinuria : Paroxysmal Nocturnal Haemoglobinuria : 2009-11-20 Completed : Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients : Hemoglobinuria, Paroxysmal : 2010-10-18 Completed : Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent PNH Subjects : Hemoglobinuria, Paroxysmal : 2009-03-23 : Drug: Eculizumab Other Name: Soliris Completed : The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) : Hemoglobinuria, Paroxysmal : 2008-07-23 Approved for marketing : The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol : Hemoglobinuria, Paroxysmal : 2007-02-20 : Drug: eculizumab 600mg IV every week and 900mg IV every 2 weeks Completed : Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients : Hemoglobinuria, Paroxysmal : 2005-07-18 : Drug: eculizumab Completed : Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab : Hemoglobinuria, Paroxysmal : 2005-07-19 : Drug: eculizumab <<< Previous | Next >>>